SEC Form 4 · accession 0001179110-18-003543
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephany Verstraete
Officer — Chief Marketing Officer
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 7:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $38.55 | Mar 1, 2018 | A | 47,300 | A | — | Mar 1, 2028 | Common Stock | 47,300 | 47,300 | D |
| Restricted Stock UnitsF2,F3 | — | Mar 1, 2018 | A | 9,507 | A | — | — | Common Stock | 9,507 | 9,507 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on March 1, 2019. The remainder of the shares will vest in 36 equal monthly installments thereafter.
- F2Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- F3The restricted stock unit vests in three equal annual installments beginning March 1, 2019.